#antibodies

Long-lived memory immune cells continue to provide protection even after antibody levels drop.

People who have had evidence of a prior infection appear to have some degree of protection against being reinfected with the virus.

Immune cells called T cells helped prevent reinfection and may be especially important if antibody levels are low or decline over time.

Agency grants emergency authorization for antibody cocktail given to President Trump.

Bamlanivimab is now authorized for nonhospitalized people at high risk for progressing to severe COVID-19.

That’s the hope of research funded by a new Campbell Foundation grant.

The treatment reduced coronavirus levels and sped up recovery in a clinical trial.

Herd immunity occurs when enough people are immune to a disease that it is unlikely to spread within a population.

Plasma from recovered patients recently received a controversial FDA emergency use authorization as a potential treatment for COVID-19.

POZ editor-in-chief Oriol R. Gutierrez Jr. shares his experiences testing antibody positive for COVID-19.

Plus: Watch a video interview series exploring the intersections between HIV and COVID-19.

Antibody analysis may provide guidance for developing vaccines and antibodies as treatments for COVID-19.

Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.

Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.

Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.

Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!